机译:评估拷贝数像差并在基因组中复制中性损失作为最佳实践:对癌症基因组学联盟(CGC)工作组的基于临床效用的基于证据审查,髓细胞转化综合征,Myelodysplastic / Myeloproiferative和Myeloproiferative肿瘤
Department of Hematopathology The University of Texas M.D. Anderson Cancer Center;
Department of Medical and Molecular Genetics Indiana University School of Medicine;
Department of Pathology and Laboratory Medicine Cancer Genetics Laboratory British Columbia;
Department of Pathology UHCMC University Hospitals and Case Western Reserve University;
Department of Pathology Microbiology and Immunology Vanderbilt University Medical Center;
IGENZ;
Department of Pathology Beth Israel Deaconess Medical Center Harvard Medical School;
West Midlands Regional Genetics Laboratory Birmingham Women's and Children's NHS Foundation Trust;
PathGroup;
Department of Pathology and Laboratory Medicine Children's Hospital of Los Angeles;
ARUP Laboratories University of Utah;
West Midlands Regional Genetics Laboratory Birmingham Women's and Children's NHS Foundation Trust;
Department of Pathology and Laboratory Medicine UCLA Clinical Genomics Center University of;
Department of Laboratory Medicine and Pathology Genomics Laboratory Mayo Clinic;
TriCore Reference Laboratories University of New Mexico;
University of Rochester Medical Center;
Fred Hutchinson Cancer Research Center and University of Washington;
Copy number aberrations; Copy neutral loss of heterozygosity; Microarray; Myelodysplastic syndrome; Myeloproliferative neoplasm; Next-generation sequencing;
机译:评估拷贝数像差并在基因组中复制中性损失作为最佳实践:对癌症基因组学联盟(CGC)工作组的基于临床效用的基于证据审查,髓细胞转化综合征,Myelodysplastic / Myeloproiferative和Myeloproiferative肿瘤
机译:在基因组中评估拷贝数异常和复制中性杂合性作为急性髓性白血病诊断评估的最佳实践:从癌症基因组学结盟(CGC)骨髓肿瘤工作组的基于循证审查
机译:评估基因组拷贝数像差和复制中性杂合子作为最佳实践:从癌细胞病毒疾病的癌症基因组学联盟工作组的基于证据的审查
机译:复制中性杂合性和总基因组畸变的中性损失对骨髓增生异常综合征生存的影响。
机译:在基因组中评估拷贝数异常和复制中性杂合性作为急性髓性白血病诊断评估的最佳实践:从癌症基因组学结盟(CGC)骨髓肿瘤工作组的基于循证审查